未登录

D

Dolores Viña

University of Santiago de Compostela

H指数:32

被引数:3,104

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting Epac1 to protect the blood brain barrier from inflammation-induced dysfunction: Evidence from an in vitro model

靶向Epac1以保护血脑屏障免受炎症诱导的功能障碍：体外模型证据

IF5.1

2025-10-140

OAAI

Antitumor Activity, Mechanisms of Action and Phytochemical Profiling of Sub-Fractions Obtained from Ulex gallii Planch. (Fabaceae): A Medicinal Plant from Galicia (Spain)

IF4.6

2025-02-190

OAAI

Effects of Sodium Nitroprusside on Lipopolysaccharide-Induced Inflammation and Disruption of Blood-Brain Barrier

硝普钠对脂多糖诱导的炎症和血脑屏障破坏的影响

IF5.2

2024-05-151

OAAI

8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin?s antidepressant profile: Synthesis, biological evaluation and docking studies

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-02-014

OAAI

Phytochemical Analysis and Antiproliferative Activity of Ulex gallii Planch. (Fabaceae), a Medicinal Plant from Galicia (Spain)

IF4.6

2023-01-012

OAAI

Antitumor activity of copper(II) complexes with Schiff bases derived from N' -tosylbenzene-1,2-diamine

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2022-11-018

OAAI

Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2022-03-221

OAAI

Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

IF4.6

2022-01-2918

OAAI

Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-09-014

OAAI

cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer's Disease

IF5.2

2021-07-3122

OAAI

Curcumin-Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders

IF4.6

2021-07-288

OAAI

Synthesis, Pharmacological, and Biological Evaluation of 2-FuroylBased MIF-1 Peptidomimetics and the Development of a GeneralPurpose Model for Allosteric Modulators (ALLOPTML)

ACS CHEMICAL NEUROSCIENCE

IF3.9

2020-12-2112

OA

7-Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation

IF3.4

2020-08-2513

PREAI

Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents

IF3.4

2020-02-2719

PREAI

New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer′s disease endowed with neurogenic properties

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2019-03-0725

OAAI

Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels

FUTURE MEDICINAL CHEMISTRY

IF3.4

2019-02-250

PREAI

Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2018-08-0137

OAAI

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease

SCIENTIFIC REPORTS

IF3.9

2018-03-13107

OAAI

Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2017-10-0144

PREAI

Computational Drug Target Screening through Protein Interaction Profiles

SCIENTIFIC REPORTS

IF3.9

2016-11-157

OAAI